Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Inc. (EBS $7.53)
- $7.53 Cap: $379M
- View EBS Profile
- View Questions on EBS

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Emergent BioSolutions Inc. (EBS $7.53)
- $7.53 Cap: $379M
- View EBS Profile
- View Questions on EBS

Q: Looking for an updated view. The large short position is either very positive or very negative.

Read Answer Asked by Jim on May 09, 2023

Quest Diagnostics Incorporated (DGX $172.07)
- $172.07 P/E (TTM): 22.53X Cap: $19.89B
- View DGX Profile
- View Questions on DGX
Hologic Inc. (HOLX $65.84)
- $65.84 P/E (TTM): 27.58X Cap: $14.56B
- View HOLX Profile
- View Questions on HOLX
Sanofi (SNY $50.32)
- $50.32 P/E (TTM): 18.86X Cap: $123.15B
- View SNY Profile
- View Questions on SNY
The Cooper Companies Inc. (COO $73.06)
- $73.06 P/E (TTM): 35.28X Cap: $14.50B
- View COO Profile
- View Questions on COO
Emergent BioSolutions Inc. (EBS $7.53)
- $7.53 Cap: $379M
- View EBS Profile
- View Questions on EBS
QuidelOrtho Corp Com (QDEL $26.72)
- $26.72 Cap: $1.72B
- View QDEL Profile
- View Questions on QDEL

Q: Would like to invest in the health sector, looking for growth over 1-2 years. Could you comment on the above stocks

Read Answer Asked by Howie on June 24, 2021

Chegg Inc. (CHGG $1.57)
- $1.57 Cap: $181M
- View CHGG Profile
- View Questions on CHGG
Emergent BioSolutions Inc. (EBS $7.53)
- $7.53 Cap: $379M
- View EBS Profile
- View Questions on EBS

Q: Peter and Ryan: Firstly let me congratulate you both on the launch of i2i and I look forward to your information rollout in the near future.
While I wait maybe you can give me some direction on two US stock that are dragging down my foreign portfolio. Both EBS and CHGG have preformed poorly this past month, should I cut my losses and redeploy elsewhere or hang in and wait?. I am open to new ideas and have a high risk tolerance.

Read Answer Asked by John on December 02, 2020